According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below:
Medpace Holdings Inc.
President, CEO and part-owner of Medpace Holdings Inc. (MEDP, Financial) August J. Troendle bought 879,565 shares this past week at a price of $23.06.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The company has a market cap of $931 million. As of Aug. 21, Â its shares traded at $28.53 with a price-earnings (P/E) ratio of -3,170.
On Aug. 10, Medpace announced the pricing of its initial public offering of 7,000,000 shares of common stock at a public offering price of $23 per share.
Troendle bought 869,565 shares of MEDP stock on Aug. 16 at a price of $23 and 10,000 shares on Aug. 18 at a price of $27.98. He purchased 879,565 shares this past week at a price of $23.06.The price of the stock has since increased by 23.72%.
Sr. Vice President of Operations Susan E. Burwig bought 19,211 shares of MEDP stock on Aug. 17 at a price of $29.21. The price of the stock has decreased by 2.33% since.
Akamai Technologies Inc.
F. Thomson Leighton, CEO of Akamai Technologies Inc. (AKAM, Financial), bought 19,003 shares on Aug. 15 at a price of $52.61. The price of the stock has increased by 0.65% since.
Akamai provides cloud services for delivering, optimizing and securing online content and business applications. The company has a market cap of $9.25 billion. As of Aug. 21, its shares traded at $52.95 with a P/E ratio of 29.06.
Revenue for the second quarter of 2016 was $572 million, a 6% increase over second quarter 2015 revenue of $541 million.
Executive Vice President of Platform, Robert Blumofe, sold 2,000 shares of AKAM stock on Aug. 1 at a price of $50.56. The price of the stock has since increased by 4.73%.
Executive Vice President and Chief HR Officer, James Gemmell, sold 1,869 shares of AKAM stock on July 28 at a price of $50.45. The price of the stock has increased by 4.96% since.
Babcock and Wilcox Enterprises Inc.
Chairman and CEO of Babcock and Wilcox Enterprises Inc. (BW, Financial), E. James Ferland Jr., bought 40,000 shares on Aug. 12 at a price of $16.22. The price of the stock has increased by 3.95% since.
Babcock and Wilcox is engaged in the manufacturing of fossil and renewable power generation equipment. The company offers a broad suite of boiler products and environmental systems, as well as services for power and industrial uses. Babcock and Wilcox has a market cap of $842.71 million. As of Aug. 21 its shares traded at $16.86 with a P/E ratio of -16.76.
The company announced second quarter 2016 revenues of $383.2 million, a decrease of $54.3 million, or 12%, compared to the second quarter of 2015.
Senior Vice President and CFO, Jenny L. Apker, bought 12,000 shares of BW stock on Aug. 15 at a price of $16.58. The price of the stock has increased by 1.69% since.
Director Thomas A. Christopher bought 2,466 shares of BW stock on Aug. 12 at a price of $16.2. The price of the stock has increased by 4.07% since.
OPKO Health Inc.
 Chairman, CEO and part-owner of OPKO Health Inc. (OPK, Financial), Phillip Frost, bought 40,000 shares during the past week at a price of $9.96.
OPKO is a biopharmaceutical and diagnostics company. It is engaged in the research and development of pharmaceutical products and vaccines. The company has a market cap of $5.38 billion. As of Aug. 21, its shares traded at $9.83 with a P/E ratio of 41.13.
Net income was $15.5 million for the quarter ending June 30, compared to net losses of $42.8 million for the comparable period of 2015. Consolidated revenue increased to $357.1 million from $42.4 million for the quarter ending June 30, compared to the 2015 period.
Frost bought 10,000 shares of OPK stock on Aug. 10 at a price of $9.98 and 10,000 shares on Aug. 15 at a price of $10.07. He also made the following purchases: 10,000 shares on Aug. 16 at a price of $10.02, 10,000 shares Aug. 17 at a price of $9.90, 10,000 shares Aug. 18 at a price of $9.87 and 40,000 shares during the past week at a price of $9.96. The price of the stock has since decreased by 1.3%.
MDC Partners Inc.
The CEO of MDC Partners Inc. (MDCA), Scott L. Kauffman, bought 10,000 shares on Aug. 12 at a price of $13.27.
MDC provides marketing, activation, communications and marketing effectiveness solutions and services to customers. Its services include media management, interactive and mobile marketing and direct marketing, among others. The company has a market cap of $704.94 million. As of Aug. 21, its shares traded at $13.18 with a P/E ratio of -11.58.
Revenue for the second quarter of 2016 was $337.0 million, an increase of 0.1%, compared to $336.6 million in the second quarter of 2015. Net income attributable to MDC Partners in the second quarter of 2016 was $1.2 million, compared to $29.6 million in the second quarter of 2015.
Kauffman bought 10,000 shares of MDCA stock on Aug. 4 at a price of $13.86. He also purchased 10,000 shares on Aug. 12 at a price of $13.27. The price of the stock has decreased by 0.68% since.
General Council and Corp. Secretary Mitchell Gendel bought 1,000 shares of MDCA stock on Aug. 8 at a price of $13.75. The price of the stock has decreased by 4.15% since.
For the complete list of stocks bought by company CEOs, go to: CEO Buys.
Disclaimer: I do not own stock in any of the companies mentioned in this article.
Start a free 7-day trial of Premium Membership to GuruFocus.
